Tag: Sanofi

  • How to Invest in the US FDA’s Approval of Type 1 Diabetes Treatment

    How to Invest in the US FDA’s Approval of Type 1 Diabetes Treatment

    For the first time, the U.S. FDA just approved a treatment to delay type 1 diabetes. According to ABC News: “Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies Provention Bio and Sanofi, is administered through intravenous infusion. The injection was shown in clinical trials to delay the…